Skip to content

Cart

Your cart is empty

Insights & News in Healthcare Safety

What Hospitals Need to Know: Using Water During Processing of Medical Devices
Infection Prevention

What Hospitals Need to Know: Using Water During Processing of Medical Devices

Every day, hospitals’ central sterile processing teams rely on water as they clean and sterilize a variety of medical devices. In this blog, ECRI outlines general considerations to support safe and...

Read more
Using Evidence to Facilitate Physician-Patient Conversations about GLP-1 RAs
Evidence-based Decision Making

Using Evidence to Facilitate Physician-Patient Conversations about GLP-1 RAs

Glucagon-like peptide receptor agonists (GLP-1 RAs) now available to promote weight loss—Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)—could potentially make much needed g...

Read more
ECRI’s Top 10 Patient Safety Concerns for 2024
Patient Safety

ECRI’s Top 10 Patient Safety Concerns for 2024

ECRI recently published our Top 10 Patient Safety Concerns for 2024 Special Report—the annual guide that calls attention to pressing patient safety concerns facing the healthcare industry. For thi...

Read more
IWD 2024: How to Continue Progress in Cervical Cancer Screening
Patient Safety

IWD 2024: How to Continue Progress in Cervical Cancer Screening

International Women’s Day is an opportune time to celebrate improvements in women’s health outcomes—and reflect on steps we can take to achieve even more progress. For this blog, we’re focusing on ...

Read more
Monitoring Patients Who Take GLP-1 RAs for Weight Loss – What Prescribers Should Know
Evidence-based Decision Making

Monitoring Patients Who Take GLP-1 RAs for Weight Loss – What Prescribers Should Know

Roughly one year after their introduction, Wegovy (semaglutide) and Zepbound (tirzepatide) continue to shake up the obesity treatment landscape in the United States. Uptake for these two glucagon-l...

Read more
Weighing the Evidence on New Weight Loss Drugs – Five Takeaways
Evidence-based Decision Making

Weighing the Evidence on New Weight Loss Drugs – Five Takeaways

The prevalence of overweight and obesity keeps worsening in America despite our enormous collective effort to lose weight. The U.S. Centers for Disease Control and Prevention estimates that overwei...

Read more
15 Years as a PSO. Decades Improving Safety.
Patient Safety

15 Years as a PSO. Decades Improving Safety.

This year, ECRI and the Institute for Safe Medication Practices PSO celebrates our 15th anniversary as an AHRQ-listed Patient Safety Organization. Over this decade and a half, we have worked tirele...

Read more
The Insidious Dangers of Disposable Isolation Gowns—and How to Address Them
Infection Prevention

The Insidious Dangers of Disposable Isolation Gowns—and How to Address Them

Isolation gowns are a longstanding infection control tool across hospital settings. These garments are intended to safeguard patients and clinicians by preventing the spread of disease-causing micr...

Read more
Exploring Oral Hygiene’s Role in Reducing Ventilator-Associated Pneumonia
Evidence-based Medicine

Exploring Oral Hygiene’s Role in Reducing Ventilator-Associated Pneumonia

Ventilator-associated pneumonia (VAP) is a lung infection that develops 48 hours or more after initiating invasive mechanical ventilation. Mechanical ventilation assists breathing in patients who h...

Read more